Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Toxicity Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia

NCT00882323 is registered in ClinicalTrials.gov with The Korean Society of Pediatric Hematology Oncology as lead sponsor.

NCT NCT00882323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00882323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Toxicity Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia
Lead sponsor
The Korean Society of Pediatric Hematology Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2008
Completion date
October 31, 2012
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia